SFRP5 and metastatic malignant neoplasm in the lymph nodes: revealed that in BC patients, SFRP5 is negatively correlated with BMI, lymph node metastasis, infiltration, TNM stage and higher Ki67 expression, and elevated SFRP5 levels were connected with the improved prognosis of BC patients (49).